CrossRef Metabolic dysfunction-associated steatotic liver disease in cushings syndrome: a case controlled FibroScan study Tugce Apaydin, Caglayan Keklikkiran, Haluk Tarik Kani, Yusuf Yilmaz, Dilek Gogas Yavuz Journal of Endocrinological Investigation .2026;[Epub] CrossRef Non-Hispanic Black Persons With HIV Have a Lower Risk of Metabolic DysfunctionAssociated Steatotic Liver Disease and Clinically Significant Fibrosis Compared to Non-Hispanic White and Hispanic Individuals Tinsay A Woreta, Samer Gawrieh, Laura A Wilson, Yuchen Xin, Eduardo Vilar-Gomez, Kathleen E Corey, Richard K Sterling, Jordan E Lake, Susanna Naggie, Sonya Heath, Holly Crandall, Jennifer C Price, Rohit Loomba, Naga Chalasani, Mark S Sulkowski Open Forum Infectious Diseases .2026;[Epub] CrossRef Development and validation of the HABIT score: a practical and robust tool to predict hepatic steatosis using HbA1c, BMI, and triglycerides in patients with unexplained elevated liver enzymes Eike Humbert, Verena Wilkens, Semjon Bugaichuk, Karoline Horvatits, Ansgar W
version 25.41.0 posted on 2025-10-14 Oct 14, 2025 Version 25.41.0 No big fixes or changes to report, just tuning things up to keep the app running smoothly
Stratified analyses showed particularly high reporting odds among men receiving Wegovy, while Ozempic-associated cases were more commonly reported in women
The Nutrient Dense range is so exciting and is also incredibly useful for anyone trying to hit their nutritional targets
doi: 10.1016/j.redox.2022.102581 87 XuX.ZhuoL.ZhangL.PengH.LyuY.SunH.et al
